RecruitingNCT07456436
Data-Driven Strategies for Patient Engagement About Cancer Clinical Trials
Sponsor
University of Southern California
Enrollment
50 participants
Start Date
Nov 26, 2024
Study Type
OBSERVATIONAL
Conditions
Summary
This study assesses patient awareness and understanding of cancer clinical trials.
Eligibility
Min Age: 21 Years
Inclusion Criteria3
- Eligible patient participants will be:
- Black/African American, Asian/Asian American, White or Hispanic adults of any gender 21 years of age or older. Race/ethnicity will be self-reported
- Have been diagnosed any cancer type
Exclusion Criteria3
- Participants (patients) will be excluded if they:
- Are unable to give informed consent
- Are unable to speak English or Spanish
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
OTHERNon-Interventional Study
Non-interventional study
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07456436
Related Trials
The Vanguard Study: Testing a New Way to Screen for Cancer
NCT0699589836 locations
Testing the Combination of the Anti-Cancer Drugs Temozolomide and M1774 to Evaluate Their Safety and Effectiveness
NCT0569149123 locations
Testing the Use of Neratinib or the Combination of Neratinib and Palbociclib Targeted Treatment for HER2+ Solid Tumors (A ComboMATCH Treatment Trial)
NCT06126276182 locations
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
NCT05334069745 locations
INTERogating Cancer for Etiology, Prevention and Therapy Navigation
NCT060083923 locations